Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

A learning path for working adults
2009-02-09

 
From the left are: Ms Maquida du Preez (MDP Programme Manager), Ms Eliche Lorandi ( Marketing Executive), Mr Theo Potgieter (BEE and Transformation Manager), Ms Marie Griebenouw (Programme Manager) and Mr Danie Jacobs (Head: Centre fro Business Dynamics).
Photo: Mangaliso Radebe
 
 In the short space of five years, the Centre for Business Dynamics at the University of the Free State (UFS) has grown in stature to such an extent that it is currently offering leadership development programmes at 45 institutions all over the country.

Speaking at the fifth anniversary of the centre’s establishment, its director, Mr Danie Jacobs, said the centre was the first commercial unit in South Africa, attached to a business school, to establish a desk focusing on Black Economic Empowerment (BEE) and Transformation in association with Empowerdex.

The main purpose of this joint venture with Empowerdex is to deliver comprehensive BEE training through the development and presentation of various programmes.

The centre has also introduced the High-Performing Directors’ Programme in association with ABSA. A total of about 40 students have enrolled for this programme so far,and their numbers fluctuate every year.

It is also the first unit in the country to link up with Thinking Fusion, one of the three consultancies contracted by the UFS, to introduce two unique leadership programmes, namely a programme in Creating Leadership and Personal Capacity in Women and the Leadership in the Connection Economy programme.

“Our aim is to prepare women for full participation as managers and leaders in transforming organizations to become truly integrated and representative of the full diversity spectrum of South Africa,” Mr Jacobs said.

“We have built amazing relationships with various clients, both in the private and public sector, over the last five years,” said Mr Jacobs. “I believe the success of the Centre for Business Dynamics lies within our methodology of action learning, as well as creating a learning path for working adults.”

“Because of our country’s history not all people are on an equal footing when it comes to prior learning, so we level the playing field by breaking the training up into easily absorbable components. The centre can address the training needs of any company because of the multiple resources that we are fortunate enough to have at our fingertips,” he said.

The centre also offers a Postgraduate Diploma in Tax Strategy and Management, aimed at bringing all parties involved in the field of taxation up to date with the latest developments and changes.

In addition, the centre has introduced The Choice and The Choice at Work programme in association with the Arbinger Institute in the United States of America. There are also two management programmes, namely the Management Preparation Programme and the Management Development Programme.

Apart from these programmes, the centre also offers products and services such as short courses, workshops and consultations.

Media Release
Issued by: Mangaliso Radebe
Assistant Director: Media Liaison
Tel: 051 401 2828
Cell: 078 460 3320
E-mail: radebemt.stg@ufs.ac.za  
9 February 2009
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept